This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Portal-systemic shunt procedures

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The use of portal-systemic shunt procedures for the treatment of acutely bleeding oesophageal varices is now reserved for the 5-10% of patients who fail to respond to pharmacotherapy or sclerotherapy.

Portal-systemic shunts have a high intraoperative mortality and a poor 5 year survival, particularly in patients with significant hepatic decompensation. The most common problem is chronic hepatic encephalopathy.

There are two types of portal-systemic shunt procedures:

  • non-selective procedures:
    • the whole portal system is decompressed
    • include the end-to-side and the side-to-side porta-caval shunts
    • carry a high risk of hepatic encephalopathy

  • selective procedures:
    • only decompress the oesophagogastric venous network
    • have a lower risk of encephalopathy
    • include the spleno-renal and the left-gastric -inferior venal cava shunts

Transjugular intrahepatic portal-systemic shunting (TIPSS) is a new procedure which is particularly useful in the treatment of acutely bleeding oesophageal varices if liver transplantation is being considered.


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.